Skip to main content
. 2022 Jan 14;2022(1):CD006311. doi: 10.1002/14651858.CD006311.pub3

2. Outcome matrix per trial group comparison.

Diagnosis Pain Function HRQoL Treatment success Withdrawals Adverse events Serious adverse events
1. CFO versus shoes
asymptomatic
flat feet
Whitford 2007 – post hoc subgroup (% pain) Whitford 2007 – VO² max, motor skills NR NR Wenger 1989;
Whitford 2007
NR NR
JIA Powell 2005 – VAS Powell 2005 – timed walk Powell 2005 – FFI Powell 2005 Powell 2005 Powell 2005 – none NR
DCD NR Morrison 2013 – 6MWT NR Morrison 2013 Morrison 2013 NR NR
2. PFO versus shoes
asymptomatic
flat feet
Whitford 2007 post hoc subgroup (% pain)
Asgaonkar 2012 – VAS
Whitford 2007 – VO² max, motor skills
Asgaonkar 2012 – HR, gait
NR Asgaonkar 2012; Gould 1989; Asgaonkar 2012; Gould 1989;
Wenger 1989;
Whitford 2007
NR NR
symptomatic
flat feet
NR Hsieh 2018 Hsieh 2018 – PODCI Hsieh 2018 Hsieh 2018 NR NR
JIA Powell 2005 – VAS Powell 2005 – timed walk Powell 2005 – FFI Powell 2005 Powell 2005 Powell 2005 – none NR
3. CFO versus PFO
asymptomatic
flat feet
Whitford 2007 – post hoc subgroup (% pain) Whitford 2007 – VO² max, motor skills NR NR Wenger 1989;
Whitford 2007
NR NR
JIA Coda 2014; Powell 2005 – VAS Powell 2005 – timed walk Coda 2014; Powell 2005 – PedsQL Coda 2014; Powell 2005; Coda 2014; Powell 2005; Coda 2014 – NR
Powell 2005 – none
NR

6MWT: 6‐minute walk test; CFO: custom foot orthoses; DCD: developmental co‐ordination disorder; HRQoL: health‐related quality of life; JIA: juvenile idiopathic arthritis; HR: heart rate; NR: not reported; PedsQL: Pediatric quality of life inventory; PFO: prefabricated foot orthoses; PODCI: Paediatric outcome data collection instrument; FFI: Foot Function index; VAS: visual analogue scale